<bill session="116" type="s" number="418" updated="2019-04-02T17:41:08Z">
  <state datetime="2019-02-07">REFERRED</state>
  <status>
    <introduced datetime="2019-02-07"/>
  </status>
  <introduced datetime="2019-02-07"/>
  <titles>
    <title type="official" as="introduced">A bill to establish procedures regarding the approval of opioid drugs by the Food and Drug Administration.</title>
    <title type="short" as="introduced">FDA Accountability for Public Safety Act</title>
    <title type="short" as="introduced">FDA Accountability for Public Safety Act</title>
    <title type="display">FDA Accountability for Public Safety Act</title>
  </titles>
  <sponsor bioguide_id="M001183"/>
  <cosponsors>
    <cosponsor bioguide_id="C001047" joined="2019-02-07"/>
    <cosponsor bioguide_id="K000383" joined="2019-02-07"/>
  </cosponsors>
  <actions>
    <action datetime="2019-02-07">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2019-02-07" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="SSHR" name="Senate Health, Education, Labor, and Pensions" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Congressional oversight"/>
    <term name="Department of Health and Human Services"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Drug trafficking and controlled substances"/>
    <term name="Federal officials"/>
    <term name="Food and Drug Administration (FDA)"/>
    <term name="Government ethics and transparency, public corruption"/>
    <term name="Marketing and advertising"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <committee-reports/>
</bill>
